SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-041038
Filing Date
2017-06-20
Accepted
2017-06-20 14:52:44
Documents
1
Period of Report
2017-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1508
  Complete submission text file 0001209191-17-041038.txt   2982
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ACHILLION PHARMACEUTICALS, INC 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
Apelian David (Reporting) CIK: 0001546842 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36183 | Film No.: 17920632